These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 12468954)
1. Extended analysis of a double-blind, placebo-controlled, 15-week study with otilonium bromide in irritable bowel syndrome. Glende M; Morselli-Labate AM; Battaglia G; Evangelista S Eur J Gastroenterol Hepatol; 2002 Dec; 14(12):1331-8. PubMed ID: 12468954 [TBL] [Abstract][Full Text] [Related]
2. Otilonium bromide in irritable bowel syndrome: a double-blind, placebo-controlled, 15-week study. Battaglia G; Morselli-Labate AM; Camarri E; Francavilla A; De Marco F; Mastropaolo G; Naccarato R Aliment Pharmacol Ther; 1998 Oct; 12(10):1003-10. PubMed ID: 9798806 [TBL] [Abstract][Full Text] [Related]
4. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome. Clavé P; Acalovschi M; Triantafillidis JK; Uspensky YP; Kalayci C; Shee V; Tack J; Aliment Pharmacol Ther; 2011 Aug; 34(4):432-42. PubMed ID: 21679214 [TBL] [Abstract][Full Text] [Related]
5. Otilonium bromide enhances sensory thresholds of volume and pressure in patients with irritable bowel syndrome. Czimmer J; Süto G; Király A; Mózsik G J Physiol Paris; 2001; 95(1-6):153-6. PubMed ID: 11595430 [TBL] [Abstract][Full Text] [Related]
6. Clinical and functional evaluation of the efficacy of otilonium bromide: a multicenter study in Italy. Baldi F; Longanesi A; Blasi A; Monello S; Cestari R; Missale G; Corazziari E; Badiali G; Pescatori M; Anastasio G Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):60-3. PubMed ID: 1756285 [TBL] [Abstract][Full Text] [Related]
7. The use of anti-spasmodics in the treatment of irritable bowel syndrome: focus on otilonium bromide. Forte E; Pizzoferrato M; Lopetuso L; Scaldaferri F Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):25-37. PubMed ID: 22338545 [TBL] [Abstract][Full Text] [Related]
9. Effect of herbal extract granules combined with otilonium bromide on irritable bowel syndrome with diarrhoea: a study protocol for a randomised controlled trial. Kim JI; Kim P; Lee JH; Kim YJ; Yang NR; Baeg MK; Choi JS; Kim HJ; Kim J; Sunwoo YY; Lee JH; Ha H; Park TY BMJ Open; 2017 Dec; 7(11):e018362. PubMed ID: 29196484 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the action of otilonium bromide and pinaverium bromide: study conducted under clinical control. Defrance P; Casini A Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):64-6. PubMed ID: 1756286 [TBL] [Abstract][Full Text] [Related]
11. Octylonium bromide in the treatment of the irritable bowel syndrome: a clinical-functional study. Baldi F; Longanesi A; Blasi A; Monello S; Cestari R; Missale G; Corazziari E; Badiali G; Marzio L; Di Felice F Hepatogastroenterology; 1992 Oct; 39(5):392-5. PubMed ID: 1459516 [TBL] [Abstract][Full Text] [Related]
12. [Otilonium bromide-diazepam in the treatment of the irritable colon. A controlled study versus otilonium bromide]. Mollica G; Manno G Clin Ter; 1992 Aug; 141(8):129-34. PubMed ID: 1395455 [TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome. Bardhan KD; Bodemar G; Geldof H; Schütz E; Heath A; Mills JG; Jacques LA Aliment Pharmacol Ther; 2000 Jan; 14(1):23-34. PubMed ID: 10632642 [TBL] [Abstract][Full Text] [Related]
14. Octatropine methyl bromide and diazepam combination (Valpinax) in patients with irritable bowel syndrome: a multicentre, randomized, placebo-controlled trial. Pace F; Maurano A; Ciacci C; Savarino V; Attili A; Iaquinto G; Magni E; Porro GB Eur Rev Med Pharmacol Sci; 2010 Mar; 14(3):155-62. PubMed ID: 20391952 [TBL] [Abstract][Full Text] [Related]
15. Irritable bowel syndrome. Spinelli A Clin Drug Investig; 2007; 27(1):15-33. PubMed ID: 17177577 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of irritable bowel syndrome with dicetelium and spasmomen]. Nedogoda SV; Parshev VV Klin Med (Mosk); 2000; 78(10):42-6. PubMed ID: 11220900 [TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Novick J; Miner P; Krause R; Glebas K; Bliesath H; Ligozio G; Rüegg P; Lefkowitz M Aliment Pharmacol Ther; 2002 Nov; 16(11):1877-88. PubMed ID: 12390096 [TBL] [Abstract][Full Text] [Related]
18. IBS and the role of otilonium bromide. Boeckxstaens G; Corazziari ES; Mearin F; Tack J Int J Colorectal Dis; 2013 Mar; 28(3):295-304. PubMed ID: 23178991 [TBL] [Abstract][Full Text] [Related]
19. Aleatory clinical study comparing otilonium bromide with a fiber-rich diet in the treatment of irritable bowel syndrome. Villagrasa M; Boix J; Humbert P; Quer JC Ital J Gastroenterol; 1991 Nov; 23(8 Suppl 1):67-70. PubMed ID: 1661630 [TBL] [Abstract][Full Text] [Related]
20. [Irritable colon syndrome: therapeutic activity of otilonium bromide alone or in combination with benzodiazepine. Controlled double-blind study]. Tarquini M; Sannino L; Bazuro G; Palomba M; Ricci C; Koch M; Fracasso P; Capurso L Clin Ter; 1984 Jun; 109(6):525-31. PubMed ID: 6236943 [No Abstract] [Full Text] [Related] [Next] [New Search]